ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Mafodotin
C49H76N6O11
925.2 g/mol
APIDanger

MC-MMAF

CAS863971-19-1
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

MC-MMAF is a chemical compound functioning as an antibody-drug conjugate payload. It features a complex structure containing multiple amide bonds, an aromatic ring, and a maleimide group for conjugation.

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing MC-MMAF?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.82

Mc-MMAE

CAS863971-24-8

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.80

Mc-MMAD

CAS1401963-15-2

research compound

SimilarStructure SimilarSimilarity 0.78

Auristatin F

CAS163768-50-1

pharmaceutical raw material

ApplicationSame Use

MC-Val-Cit-PAB-MMAF

CAS863971-17-9

pharmaceutical raw material

ApplicationSame Use

{4-[(2S)-2-[(2S)-2-(1-amino-3,6,9,12-tetraoxapentadecan-15-amido)-3-methylbutanamido]-5-(carbamoylamino)pentanamido]phenyl}methyl N-[(1S)-1-{[(1S)-1-{[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-2-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]carbamoyl}-1-methoxy-2-methyleth

CAS1492056-71-9

pharmaceutical raw material

ApplicationSame Use

Tesirin

CAS1595275-62-9

pharmaceutical raw material

ApplicationSame Use

Deruxtecan

CAS1599440-13-7

pharmaceutical raw material

ReferenceSame Category

Methylprednisolone aceponate

CAS86401-95-8

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Toxic
Toxic
Health Hazard
Health Hazard
Danger
H300Fatal if swallowed
H310Fatal in contact with skin
H330Fatal if inhaled
H341Suspected of causing genetic defects
H351Suspected of causing cancer
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name

(2S)-2-[[(2R,3R)-3-[(2S)-1-[(3R,4S,5S)-4-[[(2S)-2-[[(2S)-2-[6-(2,5-dioxopyrrol-1-yl)hexanoyl-methylamino]-3-methylbutanoyl]amino]-3-methylbutanoyl]-methylamino]-3-methoxy-5-methylheptanoyl]pyrrolidin-2-yl]-3-methoxy-2-methylpropanoyl]amino]-3-phenylpropanoic acid

InChIKey

ORFNVPGICPYLJV-YTVPMEHESA-N

SMILES

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN3C(=O)C=CC3=O

Synonyms (14)
  • MC-MMAF
  • Mafodotin (USAN)
  • Mafodotin
  • McMMAF (GMP)
  • SGD-1269(MCMMAF)?
  • mc-MMAF, mcMMAF, SGD-1269

Sourcing MC-MMAF?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→